Published in Virology on July 01, 1974
A new class of murine leukemia virus associated with development of spontaneous lymphomas. Proc Natl Acad Sci U S A (1977) 13.96
Naturally occurring murine leukemia viruses in wild mice: characterization of a new "amphotropic" class. J Virol (1976) 9.33
Growth factors from murine sarcoma virus-transformed cells. Proc Natl Acad Sci U S A (1978) 8.01
A novel murine oncornavirus with dual eco- and xenotropic properties. Proc Natl Acad Sci U S A (1975) 5.91
Changes in expression of murine leukemia virus antigens and production of xenotropic virus in the late preleukemic period in AKR mice. Proc Natl Acad Sci U S A (1976) 4.52
Isolation of transforming murine leukemia viruses from mice with a high incidence of spontaneous lymphoma. Proc Natl Acad Sci U S A (1977) 3.25
A neutralizable epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic, and amphotropic murine leukemia viruses. J Virol (1990) 3.00
High-molecular-weight RNAs of AKR, NZB, and wild mouse viruses and avian reticuloendotheliosis virus all have similar dimer structures. J Virol (1978) 2.96
Feline oncornavirus-associated cell membrane antigen: evidence for an immunologically crossreactive feline sarcoma virus-coded protein. Proc Natl Acad Sci U S A (1977) 2.93
Origin and functional properties of the major gene product of the Snyder-Theilen strain of feline sarcoma virus. Proc Natl Acad Sci U S A (1980) 2.83
Isolation from the asian mouse Mus caroli of an endogenous type C virus related to infectious primate type C viruses. Proc Natl Acad Sci U S A (1975) 2.71
Type C particle-positive and type C particle-negative rat cell lines: characterization of the coding capacity of endogenous sarcoma virus-specific RNA. J Virol (1976) 2.67
Comparison of the genomic organization of Kirsten and Harvey sarcoma viruses. J Virol (1978) 2.66
In vitro isolation of stable rat sarcoma viruses. Proc Natl Acad Sci U S A (1978) 2.41
Deletion mapping of moloney type C virus: polypeptide and nucleic acid expression in different transforming virus isolates. J Virol (1976) 2.39
Feline leukemia virus: biochemical and immunological characterization of gag gene-coded structural proteins. J Virol (1977) 2.26
Detection of receptor-specific murine leukemia virus binding to cells by immunofluorescence analysis. J Virol (1992) 2.25
Induction of GIX antigen and gross cell surface antigen after infection by ecotropic and xenotropic murine leukemia viruses in vitro. J Virol (1976) 2.11
Characterizatiion of rat genetic sequences of Kirsten sarcoma virus: distinct class of endogenous rat type C viral sequences. J Virol (1976) 2.09
Cloning and characterization of an envelope-specific probe from xenotropic murine leukemia proviral DNA. J Virol (1982) 2.09
A mouse gene on chromosome 5 that restricts infectivity of mink cell focus-forming recombinant murine leukemia viruses. J Exp Med (1983) 2.08
Mechanism of restriction of ecotropic and xenotropic murine leukemia viruses and formation of pseudotypes between the two viruses. J Virol (1977) 2.08
Pseudotypes of feline sarcoma virus contain an 85,000-dalton protein with feline oncornavirus-associated cell membrane antigen (FOCMA) activity. Proc Natl Acad Sci U S A (1978) 2.01
Virus-like 30S RNA in mouse cells. J Virol (1979) 1.99
Thermolabile reverse transcriptase of a mammalian leukemia virus mutant temperature sensitive in its replication and sarcoma virus helper functions. J Virol (1975) 1.87
Levels of rat cellular RNA homologous to either Kirsten sarcoma virus or rat type-C virus in cell lines derived from Osborne-Mendel rats. J Virol (1974) 1.86
Three independent isolates of feline sarcoma virus code for three distinct gag-x polyproteins. J Virol (1980) 1.86
Nucleic acid homology of murine xenotropic type C viruses. J Virol (1975) 1.82
Characterization of the env gene and long terminal repeat of molecularly cloned Friend mink cell focus-inducing virus DNA. J Virol (1984) 1.71
G(AKSL2): a new cell surface antigen of the mouse related to the dualtropic mink cell focus-inducing class of murine leukemia virus detected by naturally occurring antibody. J Exp Med (1979) 1.63
Characterization of proviruses cloned from mink cell focus-forming virus-infected cellular DNA. J Virol (1982) 1.60
Sequences responsible for erythroid and lymphoid leukemia in the long terminal repeats of Friend-mink cell focus-forming and Moloney murine leukemia viruses. J Virol (1987) 1.55
Abrogation of Fv-1 restriction by genome-deficient virions produced by a retrovirus packaging cell line. J Virol (1990) 1.43
Quantitative analysis of the rescue of RNA sequences by mammalian type C viruses. J Virol (1975) 1.42
Mutant feline sarcoma proviruses containing the viral oncogene (v-fes) and either feline or murine control elements. J Virol (1983) 1.38
Generation of mink cell focus-forming viruses by Friend murine leukemia virus: recombination with specific endogenous proviral sequences. J Virol (1984) 1.38
High-frequency cotransfer of the transformed phenotype and a tumor-specific transplantation antigen by DNA from the 3-methylcholanthrene-induced Meth A sarcoma of BALB/c mice. Proc Natl Acad Sci U S A (1981) 1.38
Defective endogenous proviruses are expressed in feline lymphoid cells: evidence for a role in natural resistance to subgroup B feline leukemia viruses. J Virol (1994) 1.34
Recombinant bacteriophages containing the integrated transforming provirus of Gardner--Arnstein feline sarcoma virus. Proc Natl Acad Sci U S A (1981) 1.31
Biochemical characterization of the amphotropic group of murine leukemia viruses. J Virol (1978) 1.31
Isolation and characterization of an endogenous type C RNA virus of mink (Mv1Lu) cells. J Virol (1978) 1.29
Defective Friend spleen focus-forming virus: interfering properties and isolation free from standard leukemia-inducing helper virus. J Virol (1977) 1.28
Cell surface expression of the env gene polyprotein of dual-tropic mink cell focus-forming murine leukemia virus. J Virol (1979) 1.27
Endogenous New World primate type C viruses isolated from owl monkey (Aotus trivirgatus) kidney cell line. Proc Natl Acad Sci U S A (1978) 1.26
Rescue and transmission of a replication-defective variant of moloney murine leukemia virus. J Virol (1979) 1.25
Biological, chemical, and immunological studies of Rauscher ecotropic and mink cell focus-forming viruses from JLS-V9 cells. J Virol (1983) 1.25
Mink lung epithelial cells: unique cell line that supports influenza A and B virus replication. J Clin Microbiol (1998) 1.22
Isolation of infectious xenotropic mouse type C virus by transfection of a heterologous cell with DNA from a transformed mouse cell. J Virol (1975) 1.20
Leukemia induction by a new strain of Friend mink cell focus-inducing virus: synergistic effect of Friend ecotropic murine leukemia virus. J Virol (1984) 1.19
Class II polytropic murine leukemia viruses (MuLVs) of AKR/J mice: possible role in the generation of class I oncogenic polytropic MuLVs. J Virol (1987) 1.17
Translational products encoded by newly acquired sequences of independently derived feline sarcoma virus isolates are structurally related. J Virol (1980) 1.15
Origin and biological properties of a new BALB/c mouse sarcoma virus. J Virol (1978) 1.14
Transformation-defective mutants of feline sarcoma virus which express a product of the viral src gene. J Virol (1980) 1.13
Pseudotypes of vesicular stomatitis virus with the envelope properties of mammalian and primate retroviruses. J Virol (1977) 1.12
CD4-independent infection by human immunodeficiency virus type 2 strain ROD/B: the role of the N-terminal domain of CXCR-4 in fusion and entry. J Virol (1997) 1.12
Generation of oncogenic mouse type C viruses: in vitro selection of carcinoma-inducing variants. Proc Natl Acad Sci U S A (1980) 1.09
Endogenous mink (Mustela vison) type C virus isolated from sarcoma virus-transformed mink cells. J Virol (1978) 1.08
Genomic masking and rescue of dual-tropic murine leukemia viruses: role of pseudotype virions in viral lymphomagenesis. J Virol (1980) 1.07
Generation of oncogenic type C viruses: rapidly leukemogenic viruses derived from C3H mouse cells in vivo and in vitro. Proc Natl Acad Sci U S A (1978) 1.06
Identification of a cellular receptor for mouse mammary tumor virus and mapping of its gene to chromosome 16. J Virol (1983) 1.05
The Parodi-Irgens feline sarcoma virus and simian sarcoma virus have homologous oncogenes, but in different contexts of the viral genomes. J Virol (1983) 1.05
Genome structure of mink cell focus-forming murine leukemia virus in epithelial mink lung cells transformed vitro by iododeoxyuridine-induced C3H/MuLV cells. J Virol (1983) 1.04
Liposome encapsulation of retrovirus allows efficient superinfection of resistant cell lines. J Virol (1984) 1.04
Expression of xenotropic murine leukemia viruses as cell-surface gp70 in genetic crosses between strains DBA/2 and C57BL/6. J Exp Med (1979) 1.03
A search for persistent virus infection in Crohn's disease. Gut (1980) 1.03
The prostate cancer-associated human retrovirus XMRV lacks direct transforming activity but can induce low rates of transformation in cultured cells. J Virol (2009) 1.02
CrFK feline kidney cells produce an RD114-like endogenous virus that can package murine leukemia virus-based vectors. J Virol (1998) 1.01
A multistep process of leukemogenesis in Moloney murine leukemia virus-infected mice that is modulated by retroviral pseudotyping and interference. J Virol (1996) 0.99
Amphotropic proviral envelope sequences are absent from the Mus germ line. J Virol (1987) 0.99
In vitro transformation of murine pre-B lymphoid cells by Snyder-Theilen feline sarcoma virus. J Virol (1983) 0.99
Reduced glycosylation of human cell lines increases susceptibility to CD4-independent infection by human immunodeficiency virus type 2 (LAV-2/B). J Virol (1995) 0.99
Cell-surface antigens associated with dualtropic and thymotropic murine leukemia viruses inducing thymic and nonthymic lymphomas. J Exp Med (1980) 0.98
Cationic liposomes (Lipofectin) mediate retroviral infection in the absence of specific receptors. J Virol (1990) 0.96
Fv-1 determinants in xenotropic murine leukemia viruses studied with biological assay systems: Isolation of xenotropic virus with N-tropic Fv-1 activity in the cryptic form. J Virol (1982) 0.93
Cell transformation and tumor induction by Abelson murine leukemia virus in the absence of helper virus. Proc Natl Acad Sci U S A (1987) 0.93
Mammalian cell transformation by a murine retrovirus vector containing the avian erythroblastosis virus erbB gene. J Virol (1986) 0.93
Myeloid cell transformation by ras-containing murine sarcoma viruses. Mol Cell Biol (1985) 0.93
5'-terminal nucleotide sequences of mammalian type C helper viruses are conserved in the genomes of replication-defective mammalian transforming viruses. J Virol (1978) 0.92
Glycopeptides of murine leukemia viruses. II. Comparison of xenotropic and dual-tropic viruses. J Virol (1980) 0.92
Mitogenic activity of the adenovirus type 12 E1A gene induced by hormones in rat cells. J Virol (1986) 0.91
Persistence and pathogenicity of defective Friend spleen focus-forming virus. Decreased transplantability of hemopoietic cells as a marker for preleukemic change. J Exp Med (1979) 0.90
Characterization of a feline sarcoma virus-coded antigen (FOCMA-S) by radioimmunoassay. Proc Natl Acad Sci U S A (1978) 0.89
Type C viruses from Kirsten sarcoma-transformed mink cells co-cultivated with primate cells and expressing p30 antigens related to feline leukemia virus. J Virol (1976) 0.89
A recessive cellular mutation in v-fes-transformed mink cells restores contact inhibition and anchorage-dependent growth. Mol Cell Biol (1988) 0.87
Molecular mechanisms involved in the differential expression of gag gene products by clonal isolates of a primate sarcoma virus. J Virol (1978) 0.87
Identification of the myelin protein plasmolipin as the cell entry receptor for Mus caroli endogenous retrovirus. J Virol (2008) 0.86
Type C oncornavirus isolation studies in systemic lupus erythematosus. I. Attempted detection by isopycnic sedimentation of 3H-uridine-labelled virions. Ann Rheum Dis (1975) 0.86
Spontaneous expression of C-type virus in DBA/2 mice is associated with an increased rate of mortality, independent of neoplastic disease. J Virol (1985) 0.84
DNA sequence relationship of the baboon endogenous virus genome to the genomes of other type C and type D retroviruses. J Virol (1982) 0.83
Phosphorylation of chromatin- and ribosome-associated proteins in cells transformed by adenovirus, murine sarcoma virus, and methylcholanthrene. J Virol (1978) 0.83
Productive replication and evolution of HIV-1 in ferret cells. J Virol (2011) 0.82
Leukemogenicity and cell transformation mechanisms in vitro by Gross murine leukemia virus: analysis of virus subpopulations. J Virol (1981) 0.80
The initiation of cell division in a contact-inhibited mammalian cell line. J Cell Physiol (1965) 12.07
Murine sarcoma and leukemia viruses: assay using clonal lines of contact-inhibited mouse cells. J Virol (1969) 11.78
In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst (1973) 11.26
Development of 3T3-like lines from Balb-c mouse embryo cultures: transformation susceptibility to SV40. J Cell Physiol (1968) 10.54
Growth factors from murine sarcoma virus-transformed cells. Proc Natl Acad Sci U S A (1978) 8.01
Oncogenes of RNA tumor viruses as determinants of cancer. Proc Natl Acad Sci U S A (1969) 7.69
Autocrine secretion and malignant transformation of cells. N Engl J Med (1980) 7.49
Induction of murine C-type viruses from clonal lines of virus-free BALB-3T3 cells. Science (1971) 6.71
Nerve growth factor receptors on human melanoma cells in culture. Proc Natl Acad Sci U S A (1977) 6.62
Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. Proc Natl Acad Sci U S A (1980) 6.32
Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA (1993) 5.77
Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. J Clin Oncol (1996) 4.99
Biologically active phorbol esters specifically alter affinity of epidermal growth factor membrane receptors. Nature (1979) 4.72
A type-C virus in human rhabdomyosarcoma cells after inoculation into NIH Swiss mice treated with antithymocyte serum. Proc Natl Acad Sci U S A (1973) 4.55
Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B. J Natl Cancer Inst (1998) 4.43
Basis for the acquisition of malignant potential by mouse cells cultivated in vitro. Science (1968) 4.00
Growth control in cultured cells: selection of sublines with increased sensitivity to contact inhibition and decreased tumor-producing ability. Proc Natl Acad Sci U S A (1968) 3.78
Separation of murine cellular and murine leukaemia virus DNA polymerases. Nat New Biol (1971) 3.71
Susceptibility of human diploid fibroblast strains to transformation by SV40 virus. Science (1966) 3.68
The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol (1993) 3.66
Rat transforming growth factor type 1: structure and relation to epidermal growth factor. Science (1984) 3.62
Natural history of prostatism: risk factors for acute urinary retention. J Urol (1997) 3.59
Transformation by murine and feline sarcoma viruses specifically blocks binding of epidermal growth factor to cells. Nature (1976) 3.56
erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer. J Natl Cancer Inst (1998) 3.56
Cell growth and the initiation of transformation by SV40. Proc Natl Acad Sci U S A (1966) 3.50
Transforming growth factors: isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction. Proc Natl Acad Sci U S A (1980) 3.45
Infectious C-type virus isolated from a baboon placenta. Nature (1974) 3.32
N.A.S. symposium: new evidence as the basis for increased efforts in cancer research. Proc Natl Acad Sci U S A (1972) 3.28
RNA-dependent DNA polymerase activity in five RNA viruses: divalent cation requirements. Proc Natl Acad Sci U S A (1970) 3.25
Transforming growth factors produced by retrovirus-transformed rodent fibroblasts and human melanoma cells: amino acid sequence homology with epidermal growth factor. Proc Natl Acad Sci U S A (1983) 3.21
Structure and function of human amphiregulin: a member of the epidermal growth factor family. Science (1989) 3.13
Molecular cloning and expression of an additional epidermal growth factor receptor-related gene. Proc Natl Acad Sci U S A (1990) 3.11
High frequency of SV40 transformation of mouse cell line 3T3. Virology (1966) 3.04
Evolution of type C viral genes: evidence for an Asian origin of man. Nature (1976) 3.02
A distinct class of inducible murine type-C viruses that replicates in the rabbit SIRC cell line. Proc Natl Acad Sci U S A (1974) 3.00
Membrane receptors for murine leukemia viruses: characterization using the purified viral envelope glycoprotein, gp71. Cell (1976) 2.93
Homology between type-C viruses of various species as determined by molecular hybridization. Proc Natl Acad Sci U S A (1973) 2.90
Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. Cancer Res (1997) 2.80
Evolution of C-type viral genes: inheritance of exogenously acquired viral genes. Nature (1974) 2.77
The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Engl J Med (1996) 2.74
Immunological characterization of primate C-type virus reverse transcriptases. Nat New Biol (1972) 2.73
Isolation from the asian mouse Mus caroli of an endogenous type C virus related to infectious primate type C viruses. Proc Natl Acad Sci U S A (1975) 2.71
Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing. JAMA (1995) 2.70
Detection of baboon type C viral sequences in various primate tissues by molecular hybridization. J Virol (1974) 2.69
Mouse leukemia virus: "spontaneous" release by mouse embryo cells after long-term in vitro cultivation. Proc Natl Acad Sci U S A (1969) 2.68
Immunological relationships of reverse transcriptases from ribonucleic acid tumor viruses. J Virol (1972) 2.65
Type C viruses of baboons: isolation from normal cell cultures. Cell (1974) 2.55
Circulating HER-2/erbB-2/c-neu (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer: Cancer and Leukemia Group B Study 8662. Clin Cancer Res (2001) 2.53
Nucleic acid homology of murine type-C viral genes. J Virol (1974) 2.51
Induction of cell division in medium lacking serum growth factor by SV40. Virology (1971) 2.48
The genome-associated, specific RNA binding proteins of avian and mammalian type C viruses. Cell (1977) 2.42
Cloning and sequence analysis of a cDNA for rat transforming growth factor-alpha. Nature (1985) 2.41
Properties of clonal lines of murine sarcoma virus transformed Balb-3T3 cells. Virology (1969) 2.40
Specific high affinity cell membrane receptors for biologically active phorbol and ingenol esters. Nature (1980) 2.38
RNA dependent DNA polymerase activity in mammalian cells. Nature (1971) 2.37
Epithelioid and fibroblastic rat kidney cell clones: epidermal growth factor (EGF) receptors and the effect of mouse sarcoma virus transformation. J Cell Physiol (1978) 2.36
A scanning electron microscope study of surface features of viral and spontaneous transformants of mouse Balb-3T3 cells. J Cell Biol (1973) 2.30
Epithelial wound healing enhanced by transforming growth factor-alpha and vaccinia growth factor. Science (1987) 2.24
Oncogenic RNA viruses. Semin Oncol (1976) 2.23
Improved methodology for analyzing local and distant recurrence. J Clin Oncol (1990) 2.21
The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity. Mol Cell Biol (1990) 2.21
Vaccinia virus encodes a polypeptide homologous to epidermal growth factor and transforming growth factor. Nature (1985) 2.15
Fatty acid composition of the subcutaneous adipose tissue and risk of proliferative benign breast disease and breast cancer. J Natl Cancer Inst (1993) 2.15
Recovery of SV40 virus with genetic markers of original inducing virus from SV40-transformed mouse cells. Virology (1968) 2.15
Cancer of the breast: the past decade (first of two parts). N Engl J Med (1980) 2.14
Radioimmunoassay of mammalian type C viral proteins. 3. Detection of viral antigen in normal murine cells and tissues. J Exp Med (1973) 2.13
Evolution of type C viral genes: origin of feline leukemia virus. Science (1975) 2.09
Paradigmatic shifts in the management of breast cancer. N Engl J Med (1995) 2.06
Endogenous type C virus from a cat cell clone with properties distinct from previously described feline type C virus. Virology (1973) 2.05
A population-based study of health care-seeking behavior for treatment of urinary symptoms. The Olmsted County Study of Urinary Symptoms and Health Status Among Men. Arch Fam Med (1993) 2.05
Phosphorylation of murine type C viral p12 proteins regulates their extent of binding to the homologous viral RNA. Cell (1977) 2.04
Evolution of type C viral genes: I. Nucleic acid from baboon type C virus as a measure of divergence among primate species. Proc Natl Acad Sci U S A (1974) 2.03
Pseudotypes of feline sarcoma virus contain an 85,000-dalton protein with feline oncornavirus-associated cell membrane antigen (FOCMA) activity. Proc Natl Acad Sci U S A (1978) 2.01
Stimulation of cell growth in vitro by serum with and without growth factor. Relation to contact inhibition and viral transformation. Exp Cell Res (1970) 1.99
Multiple divergent copies of endogenous C-type virogenes in mammalian cells. Nature (1974) 1.99
Two distinct endogenous type C viruses isolated from the asian rodent Mus cervicolor: conservation of virogene sequences in related rodent species. J Virol (1977) 1.98
Murine sarcoma virus transformation of BALB-3T3 cells: lack of dependence on murine leukemia virus. Proc Natl Acad Sci U S A (1970) 1.96
Differentiated cell types and the regulation of collagen synthesis. Nature (1966) 1.94
Amphiregulin: a bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocarcinoma cell line MCF-7. Proc Natl Acad Sci U S A (1988) 1.91
Rescue of endogenous 30S retroviral sequences from mouse cells by baboon type C virus. J Virol (1978) 1.90
Antibody to the RNA-dependent DNA polymerase of mammalian C-type RNA tumor viruses. Proc Natl Acad Sci U S A (1971) 1.86
Growth factors produced by sarcoma virus-transformed cells. Cancer Res (1978) 1.85
S-tropic murine type-C viruses: frequency of isolation from continuous cell lines, leukemia virus preparations and normal spleens. Int J Cancer (1974) 1.84
Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men. Br J Urol (1995) 1.82
Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer. Semin Oncol (1999) 1.82
Nucleic acid homology of murine xenotropic type C viruses. J Virol (1975) 1.82
Characterization of a type C virus released from the porcine cell line PK(15). Virology (1974) 1.81
A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol (2000) 1.81
Spontaneous release of type C viruses from clonal lines of spontaneously transformed Blab-3T3 cells. Nat New Biol (1972) 1.81
Partial purification and characterization of the SV40 T antigen. Cell (1974) 1.81
SV40 T antigen: partial purification and properties. Cold Spring Harb Symp Quant Biol (1975) 1.80
SV40 T antigen induction and transformation in human fibroblast cell strains. Virology (1968) 1.80